Ambu EBITDA Margin 2022-2025 | AMBBY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ambu (AMBBY) over the last 10 years. The current EBITDA margin for Ambu as of March 31, 2025 is .
| Ambu EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-03-31 |
$0.84B |
$0.17B |
19.79% |
| 2024-12-31 |
$0.82B |
$0.16B |
19.90% |
| 2024-09-30 |
$0.78B |
$0.15B |
18.75% |
| 2024-06-30 |
$0.76B |
$0.14B |
18.22% |
| 2024-03-31 |
$0.74B |
$0.13B |
17.21% |
| 2023-12-31 |
$0.71B |
$0.10B |
14.51% |
| 2023-09-30 |
$0.69B |
$0.09B |
13.43% |
| 2023-06-30 |
$0.66B |
$0.06B |
9.53% |
| 2023-03-31 |
$0.65B |
$0.05B |
7.88% |
| 2022-12-31 |
$0.65B |
$0.05B |
8.06% |
| 2022-09-30 |
$0.65B |
$0.05B |
7.42% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Hospitals |
$3.654B |
$0.784B |
|
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
|
